Market Cap: $14.7B
Market Cap: $14.7B
Open
$77.95
Prev. Close
$88.65
High
$78.01
Low
$76.92
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments.
Solventum Corporation trades on the New York Stock Exchange under the ticker SOLV, priced in USD.
Solventum Corporation has a market capitalisation of $14.7B, based on its latest share price.
SOLV trades at 10.31 times its trailing 12-month earnings.
Over the past 52 weeks SOLV has traded between $62.38 and $94.16.
No. Solventum Corporation does not currently pay a dividend.
Highly profitable: keeps 17.3% of revenue as net profit.
The analyst consensus rating for SOLV is Buy.
Bryan C. Hanson is the CEO of Solventum Corporation, which is headquartered in Eagan.
Generated automatically from reported financial data. General information only, not financial advice.